Mobile Platform for Optimizing Wellness and Engagement in Recovery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-63
SponsorUniversity of Michigan
About this trial
This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the feasibility and acceptability of digital CM for OUD-AUD recovery, while also planning for broader implementation.
Eligibility criteria
Qualifiers
Participants must be enrolled in the Michigan Medicaid program
Opioid agonist treatment (OAT): Participants must have initiated OAT with buprenorphine or methadone
Participants must have an OAT prescription and Alcohol use disorder (AUD) based on self-report measure during screening
Participants must have regular access to a working smartphone and internet connection.
Disqualifiers
Primary Medicare Coverage: Individuals that are dual-eligible for Medicaid and Medicare and aged 65 or older, due to limited availability of Medicaid claims data for this group
Individuals that cannot voluntarily provide informed consent themselves for any reason, including legal incompetency
Individuals with substantial cognitive impairment that would interfere with study participation
Individuals unable to read or understand English
Trial design
Treatments tested in this trial
- Digital Contingency Management Intervention Arm
- Digital Wellness Arm
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Michigan
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator
DynamiCare Health
Collaborator
Source ClinicalTrials.gov